Greek English

Contracted laboratory for Biomarkers

BIOANALYTICA GENOTYPE SA was established in December 2004 as a biotech startup aiming to provide specialised molecular cytogenetic research and application services to the biomedical Community.

 

Was funded by BIOANALYTICA SA, a leading stakeholder in the greek market for molecular diagnostics and laboratory infrastructure, and by the researcher Dr. Georgia Bardi, Associate Professor of Experimental Clinical Genetics at the Medical school of Lund University, Sweden and former Director of the Cytogenetics facility at Saint Savas Oncology hospital of Athens.

 

Is co-financed by the Greek General Secretariat of Research and Technology under the 3rd Community Support Program (03 Praxe 26).

 

 

FLOW CYTOMETRY

FLOW CYTOMETRY

FLOW CYTOMETRY
Test (genetic marker) Method Specimen Type  Turnaround Time (business days) 
Lymphocyte subpopulations with NK, T4, T8, B and γδ lymphocytes Flow Cytometry  3-5ml of blood in EDTA tube 1
Standardization of lymphoproliferative diseases  - CLL Flow Cytometry  3-5ml of blood in EDTA tube 1

Simple immunophenotyping of peripheral blood (and B lymphocyte cloning)
Flow Cytometry  3-5ml of blood in EDTA tube 1
Simple immunophenotyping of peripheral blood and subpopulation commentary (without B lymphocyte cloning) Flow Cytometry  3-5ml of blood in EDTA tube 1
Simple immunophenotyping of peripheral blood (and B lymphocyte cloning) and testing of T-Cell clonality Flow Cytometry  3-5ml of blood in EDTA tube 1

Lymphocytosis, type reversal or lymphoma cell search
Flow Cytometry  3-5ml of blood in EDTA tube 1
Simple immunophenotyping of bone marrow Flow Cytometry  2ml of bone marrow in EDTA tube 1
MRD- lymphoma Flow Cytometry  3-5ml of blood in EDTA tube 1
Blastomorphic leukemic cell typing Flow Cytometry  3-5ml of blood in EDTA tube 1

PNH in the blood
Flow Cytometry  3-5ml of blood in EDTA tube 1
DNA fragmentation and Sperm Apoptosis Flow Cytometry  Sperm 1

BioAnalytica-Genotype SA serves the healthcare market by offering Cytogenetics and Molecular Genetics tests, designed to answer questions related to diagnosis, prognosis and therapy selection for hematologic and solid tumor cancers.